Cigna Group $CI Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Cigna Group (NYSE:CIFree Report) by 9.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 276,506 shares of the health services provider’s stock after buying an additional 24,588 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.10% of Cigna Group worth $79,703,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Harbor Capital Advisors Inc. raised its stake in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the period. Solstein Capital LLC purchased a new stake in shares of Cigna Group during the second quarter worth about $29,000. Chilton Capital Management LLC purchased a new position in Cigna Group in the second quarter valued at about $30,000. Princeton Global Asset Management LLC grew its stake in Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 52 shares in the last quarter. Finally, Quaker Wealth Management LLC grew its position in shares of Cigna Group by 201.0% during the second quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock worth $35,000 after buying an additional 211 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CI has been the topic of a number of recent research reports. The Goldman Sachs Group reduced their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. Morgan Stanley reissued an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a report on Friday, October 31st. Mizuho set a $325.00 price objective on Cigna Group in a research report on Friday, January 9th. JPMorgan Chase & Co. dropped their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 4th. Finally, Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $330.48.

Get Our Latest Stock Report on CI

Insider Activity at Cigna Group

In other news, CEO David Cordani bought 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.70% of the stock is currently owned by insiders.

Cigna Group Price Performance

NYSE CI opened at $271.12 on Wednesday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The business’s fifty day moving average is $273.99 and its two-hundred day moving average is $286.17. The stock has a market capitalization of $72.42 billion, a P/E ratio of 11.96, a P/E/G ratio of 0.96 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period in the previous year, the firm posted $7.51 EPS. The company’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.